Abstract:Cardiac deletion of BSCL2 causes ATGL overexpression, excessive fatty acid oxidation (FAO), drastic reduction of cardiac lipidome and ultimately energetic and contractile dysfunction in mice. Inhibiting FAO by partial ATGL deletion or trimetazidine and increasing lipid supply via high fat diet (HFD) feeding alleviate cardiac dysfunction caused by BSCL2 deficiency. BSCL2 is a novel protein indispensable for cardiac lipid metabolism and function.BackgroundHeart failure (HF) is one of the leading causes of death worldwide and is associated with cardiac metabolic perturbations. Human Type 2 Berardinelli‐Seip Congenital Lipodystrophy (BSCL2) disease is caused by mutations in the BSCL2 gene. Global lipodystrophic Bscl2−/− mice exhibit hypertrophic cardiomyopathy with reduced cardiac steatosis. Whether BSCL2 plays a direct role in regulating cardiac substrate metabolism and/or contractile function remains unknown.MethodsWe generated mice with cardiomyocyte‐specific deletion of Bscl2 (Bscl2cKO) and studied their cardiac substrate utilisation, bioenergetics, lipidomics and contractile function under baseline or after either a treatment regimen using fatty acid oxidation (FAO) inhibitor trimetazidine (TMZ) or a prevention regimen with high‐fat diet (HFD) feeding. Mice with partial ATGL deletion and cardiac‐specific deletion of Bscl2 were also generated followed by cardiac phenotyping.ResultsDifferent from hypertrophic cardiomyopathy in Bscl2−/− mice, mice with cardiac‐specific deletion of Bscl2 developed systolic dysfunction with dilation. Myocardial BSCL2 deletion led to elevated ATGL expression and FAO along with reduced cardiac lipid contents. Cardiac dysfunction in Bscl2cKO mice was independent of mitochondrial dysfunction and oxidative stress, but associated with decreased metabolic reserve and ATP levels. Importantly, cardiac dysfunction in Bscl2cKO mice could be partially reversed by FAO inhibitor TMZ, or prevented by genetic abolishment of one ATGL allele or HFD feeding. Lipidomic analysis further identified markedly reduced glycerolipids, glycerophospholipids, NEFA and acylcarnitines in Bscl2cKO hearts, which were partially normalised by TMZ or HFD.ConclusionsWe identified a new form of cardiac dysfunction with excessive lipid utilisation which ultimately causes cardiac substrate depletion and bioenergetics failure. Our findings also uncover a crucial role of BSCL2 in controlling cardiac lipid catabolism and contractile function and provide novel insights into metabolically treating energy‐starved HF using FAO inhibitor or HFD.

Abstract P462: Bscl2/seipin Deficiency In Heart Causes Energy Deficit And Heart Failure Via Inducing Excessive Lipid Catabolism

BSCL2/Seipin deficiency in hearts causes cardiac energy deficit and dysfunction via inducing excessive lipid catabolism

Hepatic BSCL2 (Seipin) Deficiency Disrupts Lipid Droplet Homeostasis and Increases Lipid Metabolism via SCD1 Activity

Adipose Specific Disruption of Seipin Causes Early-Onset Generalised Lipodystrophy and Altered Fuel Utilisation Without Severe Metabolic Disease.

Abstract 12371: Genetic Deletion of Cystathionine Gamma Lyase in Endothelial Cells Exacerbates Cardiovascular Dysfunction in Heart Failure With Preserved Ejection Fraction

Abstract 19596: Endothelial Acyl-CoA Synthetase 1 is not Required for Saturated Fatty Acid- Mediated Inflammatory and Apoptotic Effects

Seipin Ablation in Mice Results in Severe Generalized Lipodystrophy

Overexpression of a Short Human Seipin/bscl2 Isoform in Mouse Adipose Tissue Results in Mild Lipodystrophy.

Abstract 18792: Beclin-1 Haploinsufficiency Protects Against Obesity-induced Cardiac Dysfunction Through Compensatory Mitophagy and Alternative Autophagy

Adipose-specific Knockout of SEIPIN/BSCL2 Results in Progressive Lipodystrophy.

Prohibitin 2 Deficiency Impairs Cardiac Fatty Acid Oxidation and Causes Heart Failure

Abstract 10237: Targeting on Nrf2/Sesn2 Signaling to Rescue Cardiac Dysfunction During High Fat Diet-Induced Obesity

A study of congenital generalized lipodystrophy (CGL) caused by BSCL2 gene mutation

Abstract 86: Catabolic Remodeling of Branched Chain Amino Acids in Heart Failure

Characterization of ferroptosis-triggered pyroptotic signaling in heart failure

Loss of Cardiac PFKFB2 Drives Metabolic, Functional, and Electrophysiological Remodeling in the Heart

Role of Seipin in Human Diseases and Experimental Animal Models

Lipid metabolism and signaling in cardiac lipotoxicity

Abstract 183: Branched-Chain Amino Acid Catabolic Reprogramming in Heart Failure

Abstract 13865: Cardiac Specific Deletion of Endothelin-1 Receptor a Rescues the Heart from High-Fat Diet-Induced Cardiac Dysfunction Via Regulating Autophagy

Cell-autonomous Effect of Cardiomyocyte Branched-Chain Amino Acid Catabolism in Heart Failure in Mice